Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 15;3(12):169-74.
doi: 10.4251/wjgo.v3.i12.169.

Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia

Antonio Macrì  1 , Anna Fortugno, Edoardo Saladino
Affiliations

Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia

Antonio Macrì et al. World J Gastrointest Oncol. .

Abstract

The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies. Several phase II-III studies have proved the effectiveness of the combination of cytoreductive surgery with peritoneal chemohyperthermia. Cytoreductive surgery allows the reduction of the neoplastic mass and increases tumoral chemosensitivity. The development of chemohyperthermia finds its origins in the necessity to exceed the limits of intraperitoneal chemotherapy performed in normothermia. It permits a continuous high concentration gradient of chemotherapeutic drugs between the peritoneal cavity and the plasma compartment to and a more uniform distribution throughout the abdominal cavity compared to systemic administration.

Keywords: Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Loco-regional treatments; Peritoneal carcinomatosis; Peritoneal surface malignancies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pattern of hyperthermic intraperitoneal chemotherapy. From the site: www. healthinfoispower.wordpress.com.
Figure 2
Figure 2
Kaplan-Meier curves. A: Survival probability of patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy; B: Survival probability of gastrointestinal sample; C: Survival probability of ovarian sample.
See this image and copyright information in PMC

References

    1. Deraco M, Santoro N, Carraro O, Inglese MG, Rebuffoni G, Guadagni S, Somers DC, Vaglini M. Peritoneal carcinomatosis: feature of dissemination. A review. Tumori. 1999;85:1–5. - PubMed
    1. Sugarbaker PH. Carcinomatosis from gastrointestinal cancer. Ann Med. 2004;36:9–22. - PubMed
    1. Sugarbaker PH. Managing the peritoneal surface component of gastrointestinal cancer. Part 1. Patterns of dissemination and treatment options. Oncology (Williston Park) 2004;18:51–59. - PubMed
    1. Macrì A, Saladino E, Adamo V, Altavilla G, Condemi G, Mondello E, Sinardi A, Irato S, Famulari C. The treatment of peritoneal carcinomatosis in elderly patients. BMC Geriatrics. 2010;10 Suppl 1:A11.
    1. Davies JM, O'Neil B. Peritoneal carcinomatosis of gastrointestinal origin: natural history and treatment options. Expert Opin Investig Drugs. 2009;18:913–919. - PubMed